AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Marker Therapeutics, Inc.
$1.15
-$0.39 (-25.32%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$1.2
Day Range
$1.1$1.25
Year Range
$0.84$2.46
Market Cap
19.17M
AVG Volume
66.02K
Trailing/Forward PE
-2.4/-
PEG ratio
-0.05
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQ
Video analysis: MRKR
All videosNo video analysis for this stock yet. Request one from our team.
News: MRKR
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook article.
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may prove to be good additions to one's portfolio.
